✦ LIBER ✦

Predicting Human Tumor Drug Concentrations from a Preclinical Pharmacokinetic Model of Temozolomide Brain Disposition

✍ Scribed by Zhou, Q.; Guo, P.; Kruh, G. D.; Vicini, P.; Wang, X.; Gallo, J. M.

Book ID: 111986343
Publisher: American Association for Cancer Research
Year: 2007
Tongue: English
Weight: 292 KB
Volume: 13
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-07-0658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PhRMA CPCDC initiative on predictive mod

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach

✍ Ragini Vuppugalla; Punit Marathe; Handan He; Rhys D. O. Jones; James W. T. Yates 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

From preclinical to human – prediction o

From preclinical to human – prediction of oral absorption and drug–drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example

✍ Vikash Kumar Sinha; Jan Snoeys; Nancy Van Osselaer; Achiel Van Peer; Claire Mack 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

The prediction of human response to ONO-

The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic–pharmacodynamic modeling

✍ Tomoya Ohno; Chihiro Hasegawa; Susumu Nakade; Junsaku Kitagawa; Naoki Honda; Mik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Characterization of preclinical in vitro

Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D 3 receptor antagonist candidate for treatment of drug addiction

✍ Liu, Fei; Zhuang, Xiaomei; Yang, Cuiping; Li, Zheng; Xiong, Shan; Zhang, Zhiwei; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB